The Value of ER∝ in the Prognosis of GH- and PRL-Secreting PitNETs: Clinicopathological Correlations
Pituitary neuroendocrine tumors (PitNETs) are divided into multiple histological subtypes, which determine their clinical and biological variable behavior. Despite their benign evolution, in some cases, prolactin (PRL) and growth hormone (GH)-secreting PitNETs may have aggressive behavior. In this s...
Saved in:
Published in | International journal of molecular sciences Vol. 24; no. 22; p. 16162 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Basel
MDPI AG
01.11.2023
|
Subjects | |
Online Access | Get full text |
ISSN | 1422-0067 1661-6596 1422-0067 |
DOI | 10.3390/ijms242216162 |
Cover
Abstract | Pituitary neuroendocrine tumors (PitNETs) are divided into multiple histological subtypes, which determine their clinical and biological variable behavior. Despite their benign evolution, in some cases, prolactin (PRL) and growth hormone (GH)-secreting PitNETs may have aggressive behavior. In this study, we investigated the potential predictive role of ER∝, alongside the clinicopathological classification of PitNETs (tumor diameter, tumor type, and tumor grade). A retrospective study was conducted with 32 consecutive cases of PRL- and mixed GH- and PRL-secreting PitNETs (5 patients with prolactinomas and 27 with acromegaly, among them, 7 patients with GH- and PRL- co-secretion) who underwent transsphenoidal intervention. Tumor specimens were histologically and immunohistochemical examined: anterior pituitary hormones, ki-67 labeling index, CAM 5.2, and ER∝; ER∝ expression was correlated with basal PRL levels at diagnosis (rho = 0.60, p < 0.01) and postoperative PRL levels (rho = 0.58, p < 0.001). In our study, the ER∝ intensity score was lower in female patients. Postoperative maximal tumor diameter correlated with Knosp grade (p = 0.02); CAM 5.2 pattern (densely/sparsely granulated/mixed densely and sparsely granulated) was correlated with postoperative PRL level (p = 0.002), and with ki-67 (p < 0.001). The IGF1 level at diagnosis was correlated with the postoperative GH nadir value in the oral glucose tolerance test (OGTT) (rho = 0.52, p < 0.05). Also, basal PRL level at diagnosis was correlated with postoperative tumor diameter (p = 0.63, p < 0.001). At univariate logistic regression, GH nadir in OGTT test at diagnostic, IGF1, gender, and invasion were independent predictors of remission for mixed GH- and PRL-secreting Pit-NETs; ER∝ can be used as a prognostic marker and loss of ER∝ expression should be considered a sign of lower differentiation and a likely indicator of poor prognosis. A sex-related difference can be considered in the evolution and prognosis of these tumors, but further studies are needed to confirm this hypothesis. |
---|---|
AbstractList | Pituitary neuroendocrine tumors (PitNETs) are divided into multiple histological subtypes, which determine their clinical and biological variable behavior. Despite their benign evolution, in some cases, prolactin (PRL) and growth hormone (GH)-secreting PitNETs may have aggressive behavior. In this study, we investigated the potential predictive role of ER∝, alongside the clinicopathological classification of PitNETs (tumor diameter, tumor type, and tumor grade). A retrospective study was conducted with 32 consecutive cases of PRL- and mixed GH- and PRL-secreting PitNETs (5 patients with prolactinomas and 27 with acromegaly, among them, 7 patients with GH- and PRL- co-secretion) who underwent transsphenoidal intervention. Tumor specimens were histologically and immunohistochemical examined: anterior pituitary hormones, ki-67 labeling index, CAM 5.2, and ER∝; ER∝ expression was correlated with basal PRL levels at diagnosis (rho = 0.60, p < 0.01) and postoperative PRL levels (rho = 0.58, p < 0.001). In our study, the ER∝ intensity score was lower in female patients. Postoperative maximal tumor diameter correlated with Knosp grade (p = 0.02); CAM 5.2 pattern (densely/sparsely granulated/mixed densely and sparsely granulated) was correlated with postoperative PRL level (p = 0.002), and with ki-67 (p < 0.001). The IGF1 level at diagnosis was correlated with the postoperative GH nadir value in the oral glucose tolerance test (OGTT) (rho = 0.52, p < 0.05). Also, basal PRL level at diagnosis was correlated with postoperative tumor diameter (p = 0.63, p < 0.001). At univariate logistic regression, GH nadir in OGTT test at diagnostic, IGF1, gender, and invasion were independent predictors of remission for mixed GH- and PRL-secreting Pit-NETs; ER∝ can be used as a prognostic marker and loss of ER∝ expression should be considered a sign of lower differentiation and a likely indicator of poor prognosis. A sex-related difference can be considered in the evolution and prognosis of these tumors, but further studies are needed to confirm this hypothesis.Pituitary neuroendocrine tumors (PitNETs) are divided into multiple histological subtypes, which determine their clinical and biological variable behavior. Despite their benign evolution, in some cases, prolactin (PRL) and growth hormone (GH)-secreting PitNETs may have aggressive behavior. In this study, we investigated the potential predictive role of ER∝, alongside the clinicopathological classification of PitNETs (tumor diameter, tumor type, and tumor grade). A retrospective study was conducted with 32 consecutive cases of PRL- and mixed GH- and PRL-secreting PitNETs (5 patients with prolactinomas and 27 with acromegaly, among them, 7 patients with GH- and PRL- co-secretion) who underwent transsphenoidal intervention. Tumor specimens were histologically and immunohistochemical examined: anterior pituitary hormones, ki-67 labeling index, CAM 5.2, and ER∝; ER∝ expression was correlated with basal PRL levels at diagnosis (rho = 0.60, p < 0.01) and postoperative PRL levels (rho = 0.58, p < 0.001). In our study, the ER∝ intensity score was lower in female patients. Postoperative maximal tumor diameter correlated with Knosp grade (p = 0.02); CAM 5.2 pattern (densely/sparsely granulated/mixed densely and sparsely granulated) was correlated with postoperative PRL level (p = 0.002), and with ki-67 (p < 0.001). The IGF1 level at diagnosis was correlated with the postoperative GH nadir value in the oral glucose tolerance test (OGTT) (rho = 0.52, p < 0.05). Also, basal PRL level at diagnosis was correlated with postoperative tumor diameter (p = 0.63, p < 0.001). At univariate logistic regression, GH nadir in OGTT test at diagnostic, IGF1, gender, and invasion were independent predictors of remission for mixed GH- and PRL-secreting Pit-NETs; ER∝ can be used as a prognostic marker and loss of ER∝ expression should be considered a sign of lower differentiation and a likely indicator of poor prognosis. A sex-related difference can be considered in the evolution and prognosis of these tumors, but further studies are needed to confirm this hypothesis. Pituitary neuroendocrine tumors (PitNETs) are divided into multiple histological subtypes, which determine their clinical and biological variable behavior. Despite their benign evolution, in some cases, prolactin (PRL) and growth hormone (GH)-secreting PitNETs may have aggressive behavior. In this study, we investigated the potential predictive role of ER∝, alongside the clinicopathological classification of PitNETs (tumor diameter, tumor type, and tumor grade). A retrospective study was conducted with 32 consecutive cases of PRL- and mixed GH- and PRL-secreting PitNETs (5 patients with prolactinomas and 27 with acromegaly, among them, 7 patients with GH- and PRL- co-secretion) who underwent transsphenoidal intervention. Tumor specimens were histologically and immunohistochemical examined: anterior pituitary hormones, ki-67 labeling index, CAM 5.2, and ER∝; ER∝ expression was correlated with basal PRL levels at diagnosis (rho = 0.60, p < 0.01) and postoperative PRL levels (rho = 0.58, p < 0.001). In our study, the ER∝ intensity score was lower in female patients. Postoperative maximal tumor diameter correlated with Knosp grade (p = 0.02); CAM 5.2 pattern (densely/sparsely granulated/mixed densely and sparsely granulated) was correlated with postoperative PRL level (p = 0.002), and with ki-67 (p < 0.001). The IGF1 level at diagnosis was correlated with the postoperative GH nadir value in the oral glucose tolerance test (OGTT) (rho = 0.52, p < 0.05). Also, basal PRL level at diagnosis was correlated with postoperative tumor diameter (p = 0.63, p < 0.001). At univariate logistic regression, GH nadir in OGTT test at diagnostic, IGF1, gender, and invasion were independent predictors of remission for mixed GH- and PRL-secreting Pit-NETs; ER∝ can be used as a prognostic marker and loss of ER∝ expression should be considered a sign of lower differentiation and a likely indicator of poor prognosis. A sex-related difference can be considered in the evolution and prognosis of these tumors, but further studies are needed to confirm this hypothesis. |
Audience | Academic |
Author | Zurac, Sabina Bastian, Alexandra Nastase, Valeria Nicoleta Cocosila, Laurentiu Catalin Raica, Marius Ceaușu, Raluca Amalia Dumitriu-Stan, Roxana-Ioana Burcea, Iulia-Florentina Dumitrascu, Anda Poiana, Catalina |
Author_xml | – sequence: 1 givenname: Roxana-Ioana orcidid: 0000-0003-4568-2714 surname: Dumitriu-Stan fullname: Dumitriu-Stan, Roxana-Ioana – sequence: 2 givenname: Iulia-Florentina surname: Burcea fullname: Burcea, Iulia-Florentina – sequence: 3 givenname: Valeria Nicoleta surname: Nastase fullname: Nastase, Valeria Nicoleta – sequence: 4 givenname: Raluca Amalia orcidid: 0000-0002-0067-8247 surname: Ceaușu fullname: Ceaușu, Raluca Amalia – sequence: 5 givenname: Anda surname: Dumitrascu fullname: Dumitrascu, Anda – sequence: 6 givenname: Laurentiu Catalin surname: Cocosila fullname: Cocosila, Laurentiu Catalin – sequence: 7 givenname: Alexandra surname: Bastian fullname: Bastian, Alexandra – sequence: 8 givenname: Sabina surname: Zurac fullname: Zurac, Sabina – sequence: 9 givenname: Marius surname: Raica fullname: Raica, Marius – sequence: 10 givenname: Catalina surname: Poiana fullname: Poiana, Catalina |
BookMark | eNp9kM9qGzEQxpeSQJO0x94FvfSyqf55tdtbME5SMK1J3F6FVjtyZGTJlbSUvEFfoi_XJ6kcF1IHEgSjYeb7DTPfaXXkg4eqekfwOWMd_mjXm0Q5paQhDX1VnZCS1xg34ui__HV1mtIaY8ropDupzPIO0HflRkDBoNnNn1-_kfUol-oihpUPyaZd5-q6RsoPaHEzr29BR8jWr9DC5i-zZfqEps56q8NW5bvgwspq5dA0xAhOZRt8elMdG-USvP33n1XfLmfL6XU9_3r1eXoxrzXHPNcC2k50RPSknzBMqRpUB0oPnGCgmE4aYXqghmPS9txQ3Det6odGK4Ib1k0YO6vO93NHv1X3P5VzchvtRsV7SbDcuSQPXCrAhz2wjeHHCCnLjU0anFMewpgkbTvWclZCkb5_Il2HMfpyzoMKC8o4eVStlANpvQk5Kr0bKi-E4IwSysTjngeq8gbYFB89GFvqBwDbAzqGlCIYqW1-8LaA1j17Xf2EetmNv39qsXQ |
CitedBy_id | crossref_primary_10_1210_clinem_dgae615 crossref_primary_10_1007_s12020_024_04130_6 |
Cites_doi | 10.1007/s11102-019-00982-8 10.1172/JCI0214264 10.1186/s13063-021-05604-y 10.1210/jendso/bvaa157 10.1159/000499382 10.1016/0010-7824(83)90057-4 10.1016/j.beem.2019.101290 10.1007/s00701-005-0498-2 10.1023/A:1011412028660 10.1111/cen.12242 10.3390/ijms21062024 10.1210/jc.2009-1191 10.3389/fmed.2015.00054 10.1007/s12020-019-02029-1 10.1210/jcem.86.2.7226 10.1210/jc.2013-3054 10.1007/s00234-015-1519-3 10.1038/s41598-023-42157-3 10.1046/j.0007-1331.2001.00744.x 10.4132/jptm.2016.06.30 10.1007/s11102-016-0723-4 10.1530/EJE-14-0990 10.1210/jc.2010-1692 10.1007/BF01833337 10.2174/1871530323666230511104045 10.1007/s11102-012-0426-4 10.1038/s41574-018-0058-5 10.3389/fendo.2021.684055 10.1530/EJE-07-0806 10.1007/s12022-022-09703-7 10.3389/fendo.2018.00706 10.1210/jc.2014-2700 10.1016/j.mce.2005.04.008 10.1016/j.ghir.2020.101337 10.3389/fendo.2021.793337 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2023 MDPI AG 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: COPYRIGHT 2023 MDPI AG – notice: 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | AAYXX CITATION 3V. 7X7 7XB 88E 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. M0S M1P M2O MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 ADTOC UNPAY |
DOI | 10.3390/ijms242216162 |
DatabaseName | CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Research Library Research Library (Corporate) Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic Unpaywall for CDI: Periodical Content Unpaywall |
DatabaseTitle | CrossRef Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1422-0067 |
ExternalDocumentID | 10.3390/ijms242216162 A774321237 10_3390_ijms242216162 |
GeographicLocations | Romania |
GeographicLocations_xml | – name: Romania |
GroupedDBID | --- 29J 2WC 53G 5GY 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ 8G5 A8Z AADQD AAFWJ AAHBH AAYXX ABDBF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AFKRA AFZYC ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU CITATION CS3 D1I DIK DU5 DWQXO E3Z EBD EBS EJD ESTFP ESX F5P FRP FYUFA GNUQQ GUQSH GX1 HH5 HMCUK HYE IAO IHR ITC KQ8 LK8 M1P M2O M48 MODMG O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RNS RPM TR2 TUS UKHRP ~8M ALIPV PMFND 3V. 7XB 8FK K9. MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 ADRAZ ADTOC C1A IPNFZ RIG UNPAY |
ID | FETCH-LOGICAL-c404t-7e897917b1b53022ada9eacd410e202567fbe2f4018b4f20b68abd6ca10639533 |
IEDL.DBID | M48 |
ISSN | 1422-0067 1661-6596 |
IngestDate | Tue Aug 19 23:21:52 EDT 2025 Mon Sep 08 14:50:40 EDT 2025 Fri Jul 25 21:41:43 EDT 2025 Tue Jun 17 22:19:14 EDT 2025 Tue Jun 10 21:20:32 EDT 2025 Wed Oct 01 03:04:05 EDT 2025 Thu Apr 24 23:03:48 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 22 |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 cc-by |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c404t-7e897917b1b53022ada9eacd410e202567fbe2f4018b4f20b68abd6ca10639533 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-0067-8247 0000-0003-4568-2714 |
OpenAccessLink | https://www.proquest.com/docview/2893072341?pq-origsite=%requestingapplication% |
PQID | 2893072341 |
PQPubID | 2032341 |
ParticipantIDs | unpaywall_primary_10_3390_ijms242216162 proquest_miscellaneous_2893843938 proquest_journals_2893072341 gale_infotracmisc_A774321237 gale_infotracacademiconefile_A774321237 crossref_citationtrail_10_3390_ijms242216162 crossref_primary_10_3390_ijms242216162 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-11-01 |
PublicationDateYYYYMMDD | 2023-11-01 |
PublicationDate_xml | – month: 11 year: 2023 text: 2023-11-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Basel |
PublicationPlace_xml | – name: Basel |
PublicationTitle | International journal of molecular sciences |
PublicationYear | 2023 |
Publisher | MDPI AG |
Publisher_xml | – name: MDPI AG |
References | Ozturk (ref_34) 2020; 55 McKevitt (ref_35) 2023; 13 Melmed (ref_17) 2011; 2 Roche (ref_24) 2015; 2 Kansra (ref_27) 2005; 1–2 Katznelson (ref_16) 2014; 11 Wierinckx (ref_8) 2018; 9 Melmed (ref_13) 2018; 14 ref_12 ref_10 Kim (ref_42) 2016; 6 Pollak (ref_36) 1992; 22 Raverot (ref_23) 2010; 4 Asa (ref_43) 2022; 33 Chanson (ref_1) 2019; 33 Chen (ref_40) 2021; 12 Hulting (ref_29) 1983; 1 Besser (ref_2) 1993; 129 Trouillas (ref_18) 2019; 1 Zandbergen (ref_14) 2021; 1 Moraes (ref_3) 2013; 79 Monsalves (ref_41) 2014; 99 Bima (ref_11) 2021; 12 Cozzi (ref_4) 2023; 23 Delgrange (ref_19) 2015; 172 Delgrange (ref_20) 2013; 1 Karavitaki (ref_26) 2007; 2 Heaney (ref_9) 2002; 109 Klein (ref_15) 2001; 86 Shimon (ref_37) 2012; 15 Kreutz (ref_22) 2015; 7 Jiang (ref_5) 2019; 66 Shimon (ref_21) 2016; 4 Fusco (ref_33) 2008; 5 Manoranjan (ref_6) 2010; 30 Shupnik (ref_28) 2002; 2 Orrego (ref_31) 2000; 3 Jaquet (ref_32) 1999; 9 Bazuhair (ref_25) 2023; 15 Marroni (ref_38) 2004; 3 ref_7 Delgrange (ref_30) 2005; 7 Pappy (ref_39) 2019; 22 |
References_xml | – volume: 22 start-page: 520 year: 2019 ident: ref_39 article-title: Predictive modeling for pituitary adenomas: Single center experience in 501 consecutive patients publication-title: Pituitary doi: 10.1007/s11102-019-00982-8 – volume: 109 start-page: 277 year: 2002 ident: ref_9 article-title: Functional role of estrogen in pituitary tumor pathogenesis publication-title: J. Clin. Investig. doi: 10.1172/JCI0214264 – volume: 1 start-page: 653 year: 2021 ident: ref_14 article-title: The PRolaCT studies—A study protocol for a combined randomised clinical trial and observational cohort study design in prolactinoma publication-title: Trials doi: 10.1186/s13063-021-05604-y – ident: ref_10 doi: 10.1210/jendso/bvaa157 – volume: 1 start-page: 70 year: 2019 ident: ref_18 article-title: Clinical, Pathological, and Molecular Factors of Aggressiveness in Lactotroph Tumours publication-title: Neuroendocrinology doi: 10.1159/000499382 – volume: 1 start-page: 69 year: 1983 ident: ref_29 article-title: Oral contraceptive steroids do not promote the development or growth of prolactinomas publication-title: Contraception doi: 10.1016/0010-7824(83)90057-4 – volume: 33 start-page: 1012 year: 2019 ident: ref_1 article-title: The epidemiology, diagnosis and treatment of Prolactinomas: The old and the new publication-title: Best Pract. Res. Clin. Endocrinol. Metab. doi: 10.1016/j.beem.2019.101290 – volume: 7 start-page: 751 year: 2005 ident: ref_30 article-title: Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance publication-title: Acta Neurochir. doi: 10.1007/s00701-005-0498-2 – volume: 3 start-page: 189 year: 2000 ident: ref_31 article-title: Rapid re-expansion of a macroprolactinoma after early discontinuation of bromocriptine publication-title: Pituitary doi: 10.1023/A:1011412028660 – volume: 79 start-page: 447 year: 2013 ident: ref_3 article-title: Giant prolactinomas: The therapeutic approach publication-title: Clin. Endocrinol. doi: 10.1111/cen.12242 – ident: ref_7 doi: 10.3390/ijms21062024 – volume: 4 start-page: 1708 year: 2010 ident: ref_23 article-title: Prognostic factors in prolactin pituitary tumors: Clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2009-1191 – volume: 2 start-page: 54 year: 2015 ident: ref_24 article-title: Deregulation of miR-183 and KIAA0101 in Aggressive and Malignant Pituitary Tumors publication-title: Front. Med. doi: 10.3389/fmed.2015.00054 – volume: 66 start-page: 310 year: 2019 ident: ref_5 article-title: Mammosomatotroph and mixed somatotroph-lactotroph adenoma in acromegaly: A retrospective study with long-term follow-up publication-title: Endocrine doi: 10.1007/s12020-019-02029-1 – volume: 86 start-page: 656 year: 2001 ident: ref_15 article-title: Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem.86.2.7226 – volume: 99 start-page: 1330 year: 2014 ident: ref_41 article-title: Growth Patterns of Pituitary Adenomas and Histopathological Correlates publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2013-3054 – volume: 7 start-page: 679 year: 2015 ident: ref_22 article-title: Intensity of prolactinoma on T2-weighted magnetic resonance imaging: Towards another gender difference publication-title: Neuroradiology doi: 10.1007/s00234-015-1519-3 – volume: 9 start-page: 3268 year: 1999 ident: ref_32 article-title: Quantitative and functional expression of somatostatin receptor subtypes in human prolactinomas publication-title: J. Clin. Endocrinol. Metab. – volume: 13 start-page: 15409 year: 2023 ident: ref_35 article-title: Supervised machine learning to validate a novel scoring system for the prediction of disease remission of functional pituitary adenomas following transsphenoidal surgery publication-title: Sci Rep. doi: 10.1038/s41598-023-42157-3 – volume: 30 start-page: 2897 year: 2010 ident: ref_6 article-title: Estrogen receptors alpha and beta immunohistochemical expression: Clinicopathological correlations in pituitary adenomas publication-title: Anticancer Res. – volume: 2 start-page: 85 year: 2002 ident: ref_28 article-title: Oestrogen receptors, receptor variants and oestrogen actions in the hypothalamic-pituitary axis publication-title: J. Neuroendocrinol. doi: 10.1046/j.0007-1331.2001.00744.x – volume: 6 start-page: 419 year: 2016 ident: ref_42 article-title: The Predictive Value of Pathologic Features in Pituitary Adenoma and Correlation with Pituitary Adenoma Recurrence publication-title: J. Pathol. Transl. Med. doi: 10.4132/jptm.2016.06.30 – volume: 4 start-page: 429 year: 2016 ident: ref_21 article-title: Giant prolactinomas larger than 60 mm in size: A cohort of massive and aggressive prolactin-secreting pituitary adenomas publication-title: Pituitary doi: 10.1007/s11102-016-0723-4 – volume: 172 start-page: 791 year: 2015 ident: ref_19 article-title: Expression of estrogen receptor alpha is associated with prolactin pituitary tumor prognosis and supports the sex-related difference in tumor growth publication-title: Eur. J. Endocrinol. doi: 10.1530/EJE-14-0990 – ident: ref_12 – volume: 1 start-page: 31 year: 2013 ident: ref_20 article-title: Giant prolactinomas in women publication-title: Eur. J. Endocrinol. – volume: 2 start-page: 273 year: 2011 ident: ref_17 article-title: Diagnosis and treatment of hyperprolactinemia: An Endocrine Society clinical practice guideline publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2010-1692 – volume: 129 start-page: 27 year: 1993 ident: ref_2 article-title: Criteria for medical as opposed to surgical treatment of prolactinomas publication-title: Acta Endocrinol. – volume: 3 start-page: 119 year: 2004 ident: ref_38 article-title: Immunohistochemical detection of estrogen receptor alpha in pituitary adenomas and its correlation with cellular replication publication-title: Neuroendocrinology – volume: 22 start-page: 91 year: 1992 ident: ref_36 article-title: Tamoxifen reduces serum insulin-like growth factor I (IGF-I) publication-title: Breast Cancer Res. Treat. doi: 10.1007/BF01833337 – volume: 2 start-page: 143 year: 2007 ident: ref_26 article-title: What are the markers of aggressiveness in prolactinomas? Changes in cell biology, extracellular matrix components, angiogenesis and genetics publication-title: Eur. J. Endocrinol. – volume: 23 start-page: 1459 year: 2023 ident: ref_4 article-title: Italian Guidelines for the Management of Prolactinomas publication-title: Endocr. Metab. Immune Disord. Drug Targets doi: 10.2174/1871530323666230511104045 – volume: 15 start-page: 601 year: 2012 ident: ref_37 article-title: Estrogen treatment for acromegaly publication-title: Pituitary doi: 10.1007/s11102-012-0426-4 – volume: 14 start-page: 552 year: 2018 ident: ref_13 article-title: A Consensus Statement on acromegaly therapeutic outcomes publication-title: Nat. Rev. Endocrinol. doi: 10.1038/s41574-018-0058-5 – volume: 15 start-page: e35171 year: 2023 ident: ref_25 article-title: Effect of Tamoxifen on the Management of Dopamine Agonist-Resistant Prolactinomas: A Systematic Review publication-title: Cureus. – volume: 12 start-page: 684055 year: 2021 ident: ref_11 article-title: Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results from a Pilot Study publication-title: Front. Endocrinol. doi: 10.3389/fendo.2021.684055 – volume: 5 start-page: 595 year: 2008 ident: ref_33 article-title: Somatostatinergic ligands in dopamine-sensitive and -resistant prolactinomas publication-title: Eur. J. Endocrinol. doi: 10.1530/EJE-07-0806 – volume: 33 start-page: 6 year: 2022 ident: ref_43 article-title: Overview of the 2022 WHO Classification of Pituitary Tumors publication-title: Endocr. Pathol. doi: 10.1007/s12022-022-09703-7 – volume: 9 start-page: 706 year: 2018 ident: ref_8 article-title: Sex-Related Differences in Lactotroph Tumor Aggressiveness Are Associated with a Specific Gene-Expression Signature and Genome Instability publication-title: Front. Endocrinol. doi: 10.3389/fendo.2018.00706 – volume: 11 start-page: 3933 year: 2014 ident: ref_16 article-title: Acromegaly: An endocrine society clinical practice guideline publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2014-2700 – volume: 1–2 start-page: 27 year: 2005 ident: ref_27 article-title: Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release publication-title: Mol. Cell. Endocrinol. doi: 10.1016/j.mce.2005.04.008 – volume: 55 start-page: 101337 year: 2020 ident: ref_34 article-title: The significance of estrogen receptors in acromegaly: Are they useful as predictors of prognosis and therapy regimen? publication-title: Growth Horm. IGF Res. doi: 10.1016/j.ghir.2020.101337 – volume: 12 start-page: 793337 year: 2021 ident: ref_40 article-title: Analysis of Related Factors of Tumor Recurrence or Progression After Transnasal Sphenoidal Surgical Treatment of Large and Giant Pituitary Adenomas and Establish a Nomogram to Predict Tumor Prognosis publication-title: Front. Endocrinol. doi: 10.3389/fendo.2021.793337 |
SSID | ssj0023259 |
Score | 2.4196036 |
Snippet | Pituitary neuroendocrine tumors (PitNETs) are divided into multiple histological subtypes, which determine their clinical and biological variable behavior.... |
SourceID | unpaywall proquest gale crossref |
SourceType | Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 16162 |
SubjectTerms | Cabergoline Cancer Cell growth Clinical medicine Dopamine Estrogens Females Gender differences Glucose tolerance tests Growth factors Health aspects Hyperplasia Kinases Lanreotide Medical colleges Patients Pituitary gland Prognosis Prolactin Somatotropin Surgery Transcription factors Tumorigenesis Tumors Women |
SummonAdditionalLinks | – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3bThsxEB1RECp9QFxFykVGqtqXWmS9d14QQglRBSiiUPG2sr22FBR2UzZRxR_wE_wcX8JM1gkEqbza3l3LM5454x3PAfiGGEHbhO5t5VLywIa4peIg536ijNKWGui84_wi6lwHv27CG3fgVrm0yolNHBvqvNR0Rn6AgQGqo0CjezT4y4k1iv6uOgqNT7DgCdQkuinePp0GXL4Yk6V56IN4FKZRXWPTxzD_oHd7V6F3Egh4IjHjk95b5i_weVQM5MM_2e-_cT3tFVh2mJEd10JehTlTrMFizSL5sA4WRc3-yP7IsNKy1uXz4xPrFQyRHevel5RI16uo57TDmSxy1r08478JLVLGM-v2hhetq-qQ1RVCS6IonhhEdkLcHS5bbgOu262rkw539AlcB81gyGOTpDFGY8pTRA0kZC5TNLN54DWNIKgTW2WExQArUYEVTRUlUuWRlh7BFoSBmzBflIXZAmYClYbYHlqMv3SYpLIpQ0X5sSIKfWkb8HOygJl2tcWJ4qKfYYxB653NrHcDvk-HD-qiGv8b-IOkkdFmw_dp6e4M4KyobFV2jODVJ-cbN2BnZiRuEj3bPZFn5jZplb2qVAP2p930JCWeFaYc1WMSBG1-gnOZ6sHHs_768ce2YYk46-sLjTswP7wfmV1ENkO1N1bfFxjV9EI priority: 102 providerName: ProQuest |
Title | The Value of ER∝ in the Prognosis of GH- and PRL-Secreting PitNETs: Clinicopathological Correlations |
URI | https://www.proquest.com/docview/2893072341 https://www.proquest.com/docview/2893843938 https://www.mdpi.com/1422-0067/24/22/16162/pdf?version=1699607040 |
UnpaywallVersion | publishedVersion |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVFSB databaseName: Free Full-Text Journals in Chemistry customDbUrl: eissn: 1422-0067 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0023259 issn: 1661-6596 databaseCode: HH5 dateStart: 20000101 isFulltext: true titleUrlDefault: http://abc-chemistry.org/ providerName: ABC ChemistRy – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1422-0067 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0023259 issn: 1661-6596 databaseCode: KQ8 dateStart: 20000101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1422-0067 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0023259 issn: 1661-6596 databaseCode: KQ8 dateStart: 20070101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1422-0067 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0023259 issn: 1661-6596 databaseCode: ABDBF dateStart: 20081201 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1422-0067 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0023259 issn: 1661-6596 databaseCode: DIK dateStart: 20000101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1422-0067 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0023259 issn: 1661-6596 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVAQN databaseName: PubMed Central (Free e-resource, activated by CARLI) customDbUrl: eissn: 1422-0067 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0023259 issn: 1661-6596 databaseCode: RPM dateStart: 20070101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1422-0067 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0023259 issn: 1661-6596 databaseCode: 7X7 dateStart: 20000301 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1422-0067 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0023259 issn: 1661-6596 databaseCode: BENPR dateStart: 20000301 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Technology Collection customDbUrl: eissn: 1422-0067 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0023259 issn: 1661-6596 databaseCode: 8FG dateStart: 20000301 isFulltext: true titleUrlDefault: https://search.proquest.com/technologycollection1 providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Open Access Journals customDbUrl: eissn: 1422-0067 dateEnd: 20250831 omitProxy: true ssIdentifier: ssj0023259 issn: 1661-6596 databaseCode: M48 dateStart: 20070101 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3bahsxEB0Sh5D2oaS5EKeOUaC0L1Vjr7VeuVBKEnyhNMa4dvHbIu1K4LLZdXyh9R_0J_pz-ZLMZHdN3DahL_sgaYWQRjNnpNEcgNeIEQIr6d1WqBQX1sUt5YmQ16Q2OrBUQOcdV916Zyg-j9zRBuRxutkEzv7p2hGf1HAavf95s_yEG_4jeZzosp-Nv1_P0NI4CF5wZ09uOHFK0d1rRrCxCVtopxyS-SuxumNAKHFPpUaHIJyUdpqB8-8e1yzWn3r7Oews4ola_lBR9MAwtXbhRYYo2XkqAi9hw8R7sJ1yTC73waIgsG8qWhiWWNbs3_76zcYxQ9zHetOEwuzGM6ppdzhTcch6_S_8K2FJiodmvfG82xzMPrA0f2hCBMa5umSXxOyRxdIdwLDVHFx2eEauwANREXPuGdnw0FfTVU3EQY4KVQOVcCiqFeMQEPKsNo5F90tqYZ2Krkulw3qgqgRqECQeQiFOYnMEzAjdcLHcteidBa5sqIpyNUXPOnW3pmwR3uUT6AdZ5nEiwIh89EBovv21-S7Cm1XzSZpy47GGb2k1fBIO7C9Q2YsCHBUltfLPEdrWyDR7RSittcQtFKxX5-vp5xLooyeK-s9BK1-E01U1_UlhabFJFmkbiZCuJnEsKzl4etTH_9HbK3hGtPbpm8cSFObThTlB8DPXZdj0Rh5-Zatdhq2LZrfXL5M5csv30n0HockFFQ |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbhMxEB1VRajwgLiKQAEjcXnB6sbrvSEhVJWUlKZRVNIqb4vttaWgsBu6iar8AT_BL_BRfAkz2d2UING3vtreXWs8njnjHc8BeIEYwbiY7m1lSnHpAtxSkcy4H2urjaMGOu846ofdE_lpFIw24FdzF4bSKhubuDTUWWHojHwHAwNUR4FG9_30OyfWKPq72lBoVGpxaBfnGLKV7w4-4Pq-FGK_M9zr8ppVgBvpyRmPbJxEGKTotibGHKEylaD1yWTbs4IQQOS0FQ7jjlhLJzwdxkpnoVFt8uYBHYCiyb8mfU9Srf5odBHg-WJJztZGn8fDIAmrmp6-n3g746_fSvSGAgFWKNZ84L-e4CZszfOpWpyryeQvV7d_G27VGJXtVkp1BzZsfheuV6yVi3vgULXYqZrMLSsc6xz__vGTjXOGSJINzgpK3BuX1POxy5nKMzY47vHPhE4pw5oNxrN-Z1i-ZVVF0oIokRsDzPaIK6TOzrsPJ1ci2AewmRe5fQjMSp0E2B44jPdMECfKU4GmfFwRBr5yLXjTCDA1dS1zotSYpBjTkLzTNXm34NVq-LQq4vG_ga9pNVLa3Pg-o-o7CjgrKpOV7iJY9snZRy3YXhuJm9KsdzfrmdZGoUwvVLgFz1fd9CQluuW2mFdjYgSJfoxzWenB5bN-dPnHnsFWd3jUS3sH_cPHcAOXwq8uU27D5uxsbp8gqprpp0tVZvDlqvfOH3k9MGE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbhMxEB1VRdweEFcRKGAkLi9Y2dh7RUKoahNSWqKotFXeFttrS0FhN3QTVfkDfoIf4XP4EmayuylBom99tb27lj2XM97xHIAXiBGMi-neVqYU912AKhX5GZextto4aqDzjk-DsH_sfxwFow341dyFobTKxiYuDXVWGDojb2NggOIo0Oi2XZ0WMdztvZ9-58QgRX9aGzqNSkT27eIMw7fy3d4u7vVLIXrdo50-rxkGuPE9f8YjGycRBiy6o4k9R6hMJWiJMr_jWUFoIHLaCocxSKx9JzwdxkpnoVEd8uwBHYai-b8SSV9SOlk0Og_2pFgStXXQ__EwSMKqvqeUidcef_1WomcUCLZCseYP__UKN-H6PJ-qxZmaTP5ye73bcKvGq2y7ErA7sGHzu3C1YrBc3AOHYsZO1GRuWeFY9_D3j59snDNElWx4WlAS37ikng99zlSeseHhAf9MSJWyrdlwPBt0j8q3rKpOWhA9cmOM2Q7xhtSZevfh-FIW9gFs5kVuHwKzvk4CbA8cxn4miBPlqUBTbq4IA6lcC940C5iauq450WtMUoxvaL3TtfVuwavV8GlV0ON_A1_TbqSk6Pg-o-r7CjgrKpmVbiNwluT4oxZsrY1EBTXr3c1-prWBKNNzcW7B81U3PUlJb7kt5tWYGAGjjHEuKzm4eNaPLv7YM7iGWpMe7A32H8MN3AlZ3avcgs3Z6dw-QYA100-Xkszgy2Wrzh_TKDSc |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Value+of+ER%E2%88%9D+in+the+Prognosis+of+GH-+and+PRL-Secreting+PitNETs%3A+Clinicopathological+Correlations&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Dumitriu-Stan%2C+Roxana-Ioana&rft.au=Burcea%2C+Iulia-Florentina&rft.au=Nastase%2C+Valeria+Nicoleta&rft.au=Ceau%C8%99u%2C+Raluca+Amalia&rft.date=2023-11-01&rft.issn=1422-0067&rft.eissn=1422-0067&rft.volume=24&rft.issue=22&rft_id=info:doi/10.3390%2Fijms242216162&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon |